A 23% growth in the topline has led to a more than doubling of the bottomline with the net margin improving to 10.8%. However, last year the company had provided for Rs.97.3 million as VRS which was included in the total expenditure. If this is taken into account the net profit has grown by 50% plus.
(Rs m) | FY1999 | FY1998 | Change |
Sales | 2,873.3 | 2,334.3 | 23.1% |
Other Income | 505.2 | 374.4 | 34.9% |
Expenditure | 2,774.0 | 2,402.2 | 15.5% |
Interest | 5.4 | 21.1 | -74.4% |
Depreciation | 76.8 | 96.7 | -20.6% |
Profit before Tax | 522.3 | 188.7 | 176.8% |
Tax | 213.0 | 62.9 | 238.6% |
Profit after Tax/(Loss) | 309.3 | 125.8 | 145.9% |
Net profit margin (%) | 10.8% | 5.4% |
For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.
For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
In this video I tell you the three Nifty ETFs I think are the best.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
There is no stopping this 11-bagger stock from significant upside.
In this video, I'll you what I think is the real reason behind yesterday's market crash.
More
Equitymaster requests your view! Post a comment on "Impressive performance from Pfizer.". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!